Zero Point Cryogenics closes deal involving National Research Council
By
Karen Unland
Zero Point Cryogenics has been awarded a contract to build an ultra-low temperature dilution refrigerator — a piece of equipment that enables researchers to explore the possibilities of quantum technology — for testing by the National Research Council of Canada.
It's a deal that will help the Edmonton-based company catapult to the next level, said CEO Christopher Cassin.
"It is a huge opportunity to showcase deep-tech for Alberta and for us as an organization," he said. "To have trust in us all the way up to the federal government, it's an honour."
The test will be funded through the Innovative Solutions Canada Testing Stream program, which partners with small and medium-sized Canadian businesses to award contracts to innovators who are developing novel solutions. The contract was awarded by Public Services and Procurement Canada.
Dilution refrigerators cost $500,000 to $2.5 million, Cassin said. The customers are big — academic institutions, government labs, or quantum computing companies — and the sales cycle is long. But a federal contract makes it a lot easier to go to the bank for the kinds of resources the company needs to keep growing.
"We are hiring, we are selling, and we are growing," Cassin said. "And we're building systems," added chief technical officer John P. Davis, who co-founded the company in 2017 at the University of Alberta and spun it out into its own space in 2021.
Davis, a physicist who has been studying the effects of ultra-low temperatures for decades, caught the entrepreneurial bug as he noticed that more and more of his students were entering industry instead of academia. "I started diving deeper and deeper into entrepreneurship ... to better help train my graduate students for their future careers," he said.
Grant applications tended to ask how his research would diversify the economy or otherwise benefit Alberta.
"I took that question very seriously," he said. "I started asking myself, how could we turn what we do in the lab into a business? What we decided was it wasn't really the research we do that we could commercialize. But it was the tools we use to do our research that we could commercialize."